Paediatric Rheumatology

The new edition of Paediatric Rheumatology is an indispensable resource for the identification and management of specific rheumatological disorders. Fully revised to provide up to date knowledge on common and rare rheumatological problems, including chapters on investigations and emergencies, this practical handbook designed for quick reference is essential reading for those who treat rheumatological conditions.

Helen E. Foster, Professor Paediatric Rheumatology, Newcastle University, UK; Honorary Consultant Paediatric Rheumatologist, Great North Children's Hospital, Newcastle upon Tyne, UK,Paul A. Brogan, Professor of Vasculitis and Honorary Consultant Paediatric Rheumatologist, University College London, UK

Helen Foster trained in adult medicine and subsequently in paediatric rheumatology. Her academic focus is to improve access to care for children with rheumatic disease. Key achievements include development of pGALS, pREMS, and free e-resources (http://www.pmmonline.org). She has published over 100 peer reviewed articles along with book chapters and is co-editor Oxford Textbook of Rheumatology, Fourth edition. Through key national and international leadership roles, she has contributed to paediatric rheumatology training, Recommendations for Transition, Standards of Care for Juvenile Idiopathic Arthritis, NHS Specialist Commissioning, NICE guidance and the UK Clinical Research Network.

Paul Brogan trained in paediatric nephrology before moving into paediatric rheumatology. His academic interests focus on systemic inflammatory diseases of the young, including genetics, biomarker discovery, and clinical trials. He has published over 100 peer reviewed papers, several international book chapters, and three previous Oxford University Press titles (two in paediatric nephrology; and the first edition of the Oxford Specialist Handbook of Paediatric Rheumatology). His programme of translational research has delivered next generation sequencing genetic testing into routine clinical practice for patients with suspected monogenic inflammation in the UK and beyond. He leads national clinical services for autoinflammation and vasculitis of the young; and is the chief investigator for several international clinical trials.